The MAGE clinical trial has commenced. Its purpose is to assess the effectiveness and safety of VTP-600 - a new immunotherapeutic agent designed for patients with non-small cell lung cancer (NSCLC). The study is overseen by Cancer Research UK.
Research conducted at the Department of Hematology, Blood Cancer and Bone Marrow Transplantation of the University Teaching Hospital in Wrocław has provided evidence of the effectiveness of vaccination in a group of patients at particular risk of severe COVID-19. They are patients after bone...
The pandemic has been with us for over two years, but it still seems far away to know all the effects of the SARS-CoV-2 virus on the human body. New symptoms of infection and its complications are continuously discovered and documented. Recently, the case of an American who in his letter to the...
Scientists at Harvard T.H. The Chan School of Public Health in Boston suggests that multiple sclerosis (MS) - an incurable disease that affects 2.8 million people worldwide - may be caused by an Epstein-Barr virus (EBV) infection.
Cardiac surgeons from the University of Maryland Medical Center in Baltimore successfully transplanted a 57-year-old man with the heart of a genetically modified pig.
We spoke with Professor Marek Jutel, president of the European Academy of Allergology and Clinical Immunology, on the use of depot venom immunotherapy in the treatment of insect venom allergy.
© 2023 Medexpress. All Rights Reserved
